Torrent Pharmaceuticals is in advanced talks with CVC Capital Partners to raise at least $1.2-1.5 billion for its proposed acquisition of r...

Torrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...

Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...

Non-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...

This is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due to market volatility ...

The US business is 20% of total revenues. As the proportion of this high-margin business grows, it will help Cipla improve profitability.

India's third largest drug maker posted a net profit of Rs 294.58 crore for the corresponding period of the previous fiscal year.

Sources indicated that Cipla is in talks to acquire companies with large manufacturing units in generics, respiratory and oncology spaces.

Cipla Medpro, the SA subsidiary of the Indian firm, has bagged the order as part of the South African government's 2015-17 National ARV ten...

The collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...

As part of its global expansion, Cipla had completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore last year.

Under the contract, which will run from July 2014 to April 2017, the company will supply drugs including Beclate 100, Becalate 200 and Asth...

As part of its global expansion, Cipla has been active in acquisitions. Last year, it completed the buyout of South African pharma firm, sa...

"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regula...

Cipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...

Cipla Medpro is a South African affiliate of Cipla. The companies enjoy a long-standing business relationship spanning two decades.

Cipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...